Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease (COPD), a respiratory disease characterized by a progressive decline in lung function, is considered to be a leading cause of morbidity and mortality. Long-acting inhaled bronchodilators, such as long-acting β(2) agonists (LABAs) or long-acting muscarinic antago...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramadan, Wijdan H, Kabbara, Wissam K, El Khoury, Ghada M, Al Assir, Sarah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634833/
https://www.ncbi.nlm.nih.gov/pubmed/26586940
http://dx.doi.org/10.2147/COPD.S88246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634833/
https://www.ncbi.nlm.nih.gov/pubmed/26586940
http://dx.doi.org/10.2147/COPD.S88246

Ejemplares similares